ISOVORIN

This brand name is authorized in Japan, Spain, UK.

Active ingredients

The drug ISOVORIN contains one active pharmaceutical ingredient (API):

1	Levofolinic acid UNII 990S25980Y - LEVOLEUCOVORIN
	Levoleucovorin is the pharmacologically active isomer of 5-formyltetrahydrofolic acid. Administration of levoleucovorin can “rescue” normal cells and thereby prevent toxicity of folic acid antagonists such as methotrexate which act by inhibiting dihydrofolate reductase.
	Read more about Levoleucovorin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ISOVORIN Solution for injection	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
V03AF04	Calcium levofolinate	V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AF Detoxifying agents for antineoplastic treatment
Discover more medicines within V03AF04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
ES	Centro de información online de medicamentos de la AEMPS	60866, 61291, 61292
GB	Medicines & Healthcare Products Regulatory Agency	101322, 46331
JP	医薬品医療機器総合機構	3929407D1160, 3929407D2108